Biophytis Alpha and Beta Analysis
| BPTSDelisted Stock | USD 7.03 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Biophytis. It also helps investors analyze the systematic and unsystematic risks associated with investing in Biophytis over a specified time horizon. Remember, high Biophytis' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Biophytis' market risk premium analysis include:
Beta (0.08) | Alpha (0.76) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Biophytis |
Biophytis Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Biophytis market risk premium is the additional return an investor will receive from holding Biophytis long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biophytis. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Biophytis' performance over market.| α | -0.76 | β | -0.08 |
Biophytis Fundamentals Vs Peers
Comparing Biophytis' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Biophytis' direct or indirect competition across all of the common fundamentals between Biophytis and the related equities. This way, we can detect undervalued stocks with similar characteristics as Biophytis or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Biophytis' fundamental indicators could also be used in its relative valuation, which is a method of valuing Biophytis by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Biophytis to competition |
| Fundamentals | Biophytis | Peer Average |
| Return On Equity | -12.44 | -0.31 |
| Return On Asset | -0.53 | -0.14 |
| Current Valuation | 9.73 B | 16.62 B |
| Shares Outstanding | 286.5 K | 571.82 M |
| Shares Owned By Institutions | 0.04 % | 39.21 % |
| Number Of Shares Shorted | 368.95 K | 4.71 M |
| Price To Book | 2.26 X | 9.51 X |
Biophytis Opportunities
Biophytis Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Biophytis launches OBA phase 2 clinical study in obesity with BIO101 | 04/08/2024 |
2 | Why Is Biophytis Stock Up 43 percent Today | 04/09/2024 |
3 | Biotech Catches Major Premarket Bid Following Financial Results - MSN | 04/15/2024 |
4 | Biophytis unveils design for obesity study - Marketscreener.com | 05/14/2024 |
5 | Biophytis Advances DMD Treatment with BIO101 Scale-Up - TipRanks.com - TipRanks | 06/14/2024 |
About Biophytis Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Biophytis or other delisted stocks. Alpha measures the amount that position in Biophytis has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Biophytis Upcoming Company Events
As portrayed in its financial statements, the presentation of Biophytis' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biophytis' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Biophytis' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Biophytis. Please utilize our Beneish M Score to check the likelihood of Biophytis' management manipulating its earnings.
| 16th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 16th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Biophytis
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Biophytis Stock
If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |